openPR Logo
Press release

Digital Diabetes Management Market Robust Expansion is expected to 2031

12-26-2024 09:50 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Digital Diabetes Management Market

Digital Diabetes Management Market

Digital Diabetes Management Market to reach over USD 49.5 Bn by the year 2031 - Explained Details | Exclusive Study by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals & Speciality Diabetes Clinics And Academic & Research Institutes))), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

Get Free Access to Demo Report, Excel Pivot and ToC : www.insightaceanalytic.com/request-sample/1487

"Digital Diabetes Management Market" in terms of revenue was estimated to be worth $18.11 billion in 2023 and is poised to reach $49.48 billion by 2031, growing at a CAGR of 13.58% from 2024 to 2031 according to a new report by InsightAce Analytic.

Recent Developments:
• In January 2024, Tandem Diabetes Care, Inc. announced that their t: slim X2 insulin pump with Control-IQ technology is the first AID system to connect with Abbott's latest continuous glucose monitoring (CGM) device, the FreeStyle Libre 2 Plus.
• In November 2023, Ascensia Diabetes Care Poland was recognized as a Great Place to Work by the esteemed organization. Ascensia Diabetes Care is a worldwide leader in diabetes care, known for its CONTOUR Blood Glucose Monitoring (BGM) System portfolio and its exclusive distribution of Eversense Continuous Glucose Monitoring (CGM) Systems.
• In October 2023, Insulet recently made headlines when it announced that the FDA had cleared its Omnipod 5 App for iPhone under the 510(k) program. This makes Insulet the only company in the world to offer a tubeless automated insulin delivery (AID) system that can be fully controlled from an Android or iOS smartphone.

Expert Knowledge, Just a Click Away:https://calendly.com/insightaceanalytic/30min?month=2024-02

Latest Drivers Restraint and Opportunities Market Snapshot:

Key factors influencing the digital diabetes management market are:
• Technological advancements
• Combining therapeutic and monitoring capabilities
• Artificial intelligence and data analytics integration

The following are the primary obstacles to the digital diabetes management market 's expansion:
• High cost
• Lack of awareness
• privacy issues about data

Future expansion opportunities for the digital diabetes management market include:
• Increasingly popular usage of interconnected gadgets
• Increase in the prevalence of diabetes
• Growing population

Market Analysis:

Digital diabetes management encompasses various tools, including insulin pens, sensors, smart glucose meters, closed-loop systems, insulin patches, and various software-based applications and platforms. The use of smart insulin pens has several advantages in the treatment of diabetes. Innovations in technology have opened the door for the market to receive incredibly versatile solutions. Another factor fueling the market's expansion is the proliferation of smartphone and Internet health-tracking apps.

List of Prominent Players in the Digital Diabetes Management Market:
• Medtronic
• B. Braun Melsungen AG
• Dexcom, Inc
• Abbott Laboratories
• F. Hoffmann-La Roche
• Insulet Corporation
• Tandem Diabetes Care
• Ascensia Diabetes Care Holdings AG
• LifeScan, Inc
• Tidepool
• AgaMatrix
• Glooko, Inc
• DarioHealth Corporation
• One Drop
• Dottli
• Ypsomed Holding AG
• ARKRAY
• ACON Laboratories, Inc
• Care Innovations, LLC
• Health2Sync
• Emperra GmbH E-Health Technologies
• Azumio
• Decide Clinical Software GmbH
• Pendiq GmbH
• BeatO

Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1487

Digital Diabetes Management Market Dynamics:
Market Drivers: Technological Advancement
Advancements in smart insulin pens are expected to propel the worldwide digital diabetes management industry. Smart insulin pens utilize the iSenz adapter to detect insulin levels. It provides the injection angles for optimizing injection sites for people with diabetes. Easylog is an adaptor that may be used with insulin pens linked to the internet. More and more individuals are keeping track of their health via their cell phones and the internet, fueling the expansion of the market.

Challenges: High Cost
The market's expansion will be hindered by the high expense of digital diabetes management systems and their poor uptake in developing and emerging nations. Not everyone can afford to use one of the many diabetes management programs available for mobile and desktop platforms. Doctors, nurses, and other medical staff require proper training to accurately interpret blood sugar levels. Concerns concerning patient data protection and the general public's ignorance about digital diabetes care also slow business expansion in lesser-developed nations.

North America is Expected to Grow with the Highest CAGR During the Forecast Period
The digital diabetes management market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of the growing interest in digital health and the many people dealing with long-term health conditions. In addition, the market is being propelled forward by elements including a robust supply-side infrastructure, the quick adoption of new technologies, and sufficient reimbursements.

Segmentation of Digital Diabetes Management Market-
By Product & Service
• Devices
o Smart Glucose Meters
o Continuous Glucose Monitoring (CGM) Systems
o Smart Insulin Pens
o Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
• Application
o Diabetes & Blood Glucose Tracking Apps
o Obesity & Diet Management Apps
• Data Management Software & Platforms
• Services
By Device Type
• Handheld Devices
• Wearable Devices
By End User
• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1487

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Diabetes Management Market Robust Expansion is expected to 2031 here

News-ID: 3797836 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

Organic Feminine Care Market to Benefit from Increasing Government Initiatives and Consumer Awareness on Eco-Friendly and Sustainable Products
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma AG, LFB Biotechnologies, Grifols SA, CSL Behring, China Biologics Products Inc.
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031" The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period. Get Free Access
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Company, International Business Machines Corporation, Intel Corporation, NVIDIA Corporation.
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at
Plasma Fractionation Market Robust Expansion is expected to 2031
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end